Selzentry News
Most Popular Selzentry Story
Selzentry - 2007 FDA approvals
Drug: Selzentry (maraviroc) Indication: HIV Company: Pfizer Approval Date: August 6, 2007 Scoop: Selzentry is a CCR5 antagonist, which prevents the virus from entering white blood cells. The process... Read more...
Latest Headlines
- January 30, 2008
- January 9, 2008
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
